Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo
Authors
Keywords
-
Journal
PLoS One
Volume 14, Issue 12, Pages e0225931
Publisher
Public Library of Science (PLoS)
Online
2019-12-05
DOI
10.1371/journal.pone.0225931
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma
- (2018) Meiying Luo et al. CELL DEATH AND DIFFERENTIATION
- Glutathione metabolism in cancer progression and treatment resistance
- (2018) Ankita Bansal et al. JOURNAL OF CELL BIOLOGY
- Sulfasalazine, an inhibitor of the cystine-glutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma
- (2018) Masaki Nagane et al. PLoS One
- The ferroptosis inducer erastin irreversibly inhibits system xc− and synergizes with cisplatin to increase cisplatin’s cytotoxicity in cancer cells
- (2018) Mami Sato et al. Scientific Reports
- The Role of Ferroptosis in Cancer Development and Treatment Response
- (2018) Bin Lu et al. Frontiers in Pharmacology
- Iron and Cancer
- (2018) Suzy V. Torti et al. Annual Review of Nutrition
- xCT inhibition sensitizes tumors to γ-radiation via glutathione reduction
- (2018) Lara Cobler et al. Oncotarget
- Iron-responsive element-binding protein 2 plays an essential role in regulating prostate cancer cell growth
- (2017) Zhiyong Deng et al. Oncotarget
- Iron and cancer: recent insights
- (2016) David H. Manz et al. Annals of the New York Academy of Sciences
- Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer
- (2016) Jong-Lyel Roh et al. CANCER LETTERS
- Ferroptosis is an autophagic cell death process
- (2016) Minghui Gao et al. CELL RESEARCH
- A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma
- (2016) Judith G. Villablanca et al. PEDIATRIC BLOOD & CANCER
- Enhancement of Radiation Response in Breast Cancer Stem Cells by Inhibition of Thioredoxin- and Glutathione-Dependent Metabolism
- (2016) Samuel N. Rodman et al. RADIATION RESEARCH
- Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease
- (2016) Alexander R. Bogdan et al. TRENDS IN BIOCHEMICAL SCIENCES
- Cancer cells with irons in the fire
- (2015) Laura M. Bystrom et al. FREE RADICAL BIOLOGY AND MEDICINE
- Glutaminolysis and Transferrin Regulate Ferroptosis
- (2015) Minghui Gao et al. MOLECULAR CELL
- Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc−, leading to glutathione depletion
- (2015) L Sleire et al. ONCOGENE
- Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function
- (2015) LIANGYU CHEN et al. ONCOLOGY REPORTS
- The EGFR mutation status affects the relative biological effectiveness of carbon-ion beams in non-small cell lung carcinoma cells
- (2015) Napapat Amornwichet et al. Scientific Reports
- Regulation of Ferroptotic Cancer Cell Death by GPX4
- (2014) Wan Seok Yang et al. CELL
- The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma
- (2014) A Tagde et al. Blood Cancer Journal
- Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
- (2014) Scott J Dixon et al. eLife
- Role of Glutathione in Cancer Progression and Chemoresistance
- (2013) Nicola Traverso et al. Oxidative Medicine and Cellular Longevity
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- Sulfasalazine for brain cancer fits
- (2012) Harald Sontheimer et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen
- (2009) Hany Onsy Habashy et al. BREAST CANCER RESEARCH AND TREATMENT
- Systemic Iron Homeostasis and the Iron-Responsive Element/Iron-Regulatory Protein (IRE/IRP) Regulatory Network
- (2008) Martina U. Muckenthaler et al. Annual Review of Nutrition
- Synthetic Lethal Screening Identifies Compounds Activating Iron-Dependent, Nonapoptotic Cell Death in Oncogenic-RAS-Harboring Cancer Cells
- (2008) Wan Seok Yang et al. CHEMISTRY & BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started